Cargando…
Identification of biomarkers regulated by rexinoids (LGD1069, LG100268 and Ro25-7386) in human breast cells using Affymetrix microarray
Retinoids possess anti-proliferative properties, which suggests that they possess chemopreventive and therapeutic potential against cancer. In the current study, genes modulated by rexinoids (retinoid X receptor (RXR)-pan agonists, LGD1069 and LG100268; and the RXRα agonist, Ro25-7386) were identifi...
Autores principales: | SEO, HYE-SOOK, WOO, JONG-KYU, SHIN, YONG CHEOL, KO, SEONG-GYU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438952/ https://www.ncbi.nlm.nih.gov/pubmed/25778982 http://dx.doi.org/10.3892/mmr.2015.3480 |
Ejemplares similares
-
Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
por: Abba, Martin C, et al.
Publicado: (2008) -
Prevention and Treatment of Experimental Estrogen Receptor – Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
por: Liby, Karen, et al.
Publicado: (2008) -
The “Phantom Effect” of the Rexinoid LG100754: Structural and Functional Insights
por: Sato, Yoshiteru, et al.
Publicado: (2010) -
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
por: Leal, Ana S., et al.
Publicado: (2019) -
A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
por: Yen, W-C, et al.
Publicado: (2006)